Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early treatment with tolvaptan improves diuretic response in acute heart failure with renal dysfunction.
Matsue Y, Ter Maaten JM, Suzuki M, Torii S, Yamaguchi S, Fukamizu S, Ono Y, Fujii H, Kitai T, Nishioka T, Sugi K, Onishi Y, Noda M, Kagiyama N, Satoh Y, Yoshida K, van der Meer P, Damman K, Voors AA, Goldsmith SR. Matsue Y, et al. Among authors: goldsmith sr. Clin Res Cardiol. 2017 Oct;106(10):802-812. doi: 10.1007/s00392-017-1122-1. Epub 2017 May 24. Clin Res Cardiol. 2017. PMID: 28540483 Free PMC article. Clinical Trial.
Clinical Effectiveness of Tolvaptan in Patients With Acute Heart Failure and Renal Dysfunction.
Matsue Y, Suzuki M, Torii S, Yamaguchi S, Fukamizu S, Ono Y, Fujii H, Kitai T, Nishioka T, Sugi K, Onishi Y, Noda M, Kagiyama N, Satoh Y, Yoshida K, Goldsmith SR. Matsue Y, et al. Among authors: goldsmith sr. J Card Fail. 2016 Jun;22(6):423-32. doi: 10.1016/j.cardfail.2016.02.007. Epub 2016 Feb 23. J Card Fail. 2016. PMID: 26915749 Clinical Trial.
Prognostic impact of early treatment with tolvaptan in patients with acute heart failure and renal dysfunction.
Matsue Y, Suzuki M, Torii S, Yamaguchi S, Fukamizu S, Ono Y, Fujii H, Kitai T, Nishioka T, Sugi K, Onishi Y, Noda M, Kagiyama N, Satoh Y, Yoshida K, Goldsmith SR. Matsue Y, et al. Among authors: goldsmith sr. Int J Cardiol. 2016 Oct 15;221:188-93. doi: 10.1016/j.ijcard.2016.07.063. Epub 2016 Jul 5. Int J Cardiol. 2016. PMID: 27404673 Clinical Trial.
Corrigendum to "Clinical Effectiveness of Tolvaptan in Patients With Acute Heart Failure and Renal Dysfunction" Journal of Cardiac Failure, Vol. 22, No. 6, June 2016, pp. 423-432.
Matsue Y, Suzuki M, Torii S, Yamaguchi S, Fukamizu S, Ono Y, Fujii H, Kitai T, Nishioka T, Sugi K, Onishi Y, Noda M, Kagiyama N, Satoh Y, Yoshida K, Goldsmith SR. Matsue Y, et al. Among authors: goldsmith sr. J Card Fail. 2016 Nov;22(11):941. doi: 10.1016/j.cardfail.2016.07.434. Epub 2016 Jul 29. J Card Fail. 2016. PMID: 27481596 No abstract available.
Prognostic importance of sodium level trajectory in acute heart failure.
Matsue Y, Yoshioka K, Suzuki M, Torii S, Yamaguchi S, Fukamizu S, Ono Y, Fujii H, Kitai T, Nishioka T, Sugi K, Onishi Y, Noda M, Kagiyama N, Satoh Y, Yoshida K, Goldsmith SR. Matsue Y, et al. Among authors: goldsmith sr. Heart Vessels. 2017 Dec;32(12):1498-1505. doi: 10.1007/s00380-017-1020-5. Epub 2017 Jul 11. Heart Vessels. 2017. PMID: 28698994 Clinical Trial.
Obesity and the response to intensified diuretic treatment in decompensated heart failure: a DOSE trial substudy.
Gupta A, Braunwald E, McNulty S, Felker GM, Gilbert EM, Alharethi R, Lee KL, Anstrom KJ, Redfield MM, Goldsmith SR, O'Connor CM, Bull DA, Stehlik J, Litwin SE. Gupta A, et al. Among authors: goldsmith sr. J Card Fail. 2012 Nov;18(11):837-44. doi: 10.1016/j.cardfail.2012.09.005. J Card Fail. 2012. PMID: 23141856 Free PMC article. Clinical Trial.
160 results